THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD)

CUSIP: 88427A107

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 6 signals
Share change
-38,130,815
SEC-reported price per share
$5.38
Number of holders
12
Value change
-$208,406,334
Number of buys
5
Number of sells
94
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,416,671

Security key

88427A107

Report period

Q3 2025

Institutions

12

Top holders

10

Ownership snapshot

Top reported holders of THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BML Investment Partners, ...
Disclosed value leader
Atlas Venture Fund XI, L.P.
Comparable rows
1/15
Latest evidence
30 Jun 2025
13D/G 3/4/5 13F Lead comparable stake: 8.2% 14 rows are not safely comparable across share classes. 13D/G row: BML Investment Partners, L.P. Showing 1-6 of 15 holder rows.

Quick read

BML Investment Partners, L.P. leads the comparable SEC ownership view at 8.2%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BML Investment Partners, L.P.'s linked filing trail.
Comparable ownership Top 1
BML Investment Partners, L.P. 8.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BML Investment Partners, L.P.
13D/G
8.2%
Reported 13D/G · 11 Feb 2025
$19,179,460
3,724,167 shares
$0 11 Feb 2025
Atlas Venture Fund XI, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$140,112,473
9,798,075 shares
— 01 Nov 2024
ORBIMED ADVISORS LLC
3/4/5 13F
Director, 10%+ Owner · Company
—
denominator unverified
$59,522,120
5,779,071 shares
— 19 Sep 2022
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
—
denominator unverified
$56,484,413
10,402,286 shares
— 30 Jun 2025
BML Capital Management, LLC
13F
Company
13F
—
denominator unverified
$20,766,584
3,824,417 shares
— 30 Jun 2025
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$15,957,141
2,938,700 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
12
Shares
499,952
Rows available
12
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2026 Across Filers

Q2 2026 holders
2
Q3 2025 holders
12
Holder diff
10
Investor Q2 2026 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2026 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .